Background and Purpose—Blood supply through collateral pathways improves regional
cerebral blood flow and may protect against ischemic events. The effect of collaterals on the risk …

Context The combination of multiple clinical factors culminates in neuromuscular respiratory
failure in up to 30% of the patients with Guillain-Barré syndrome (GBS). Although guidelines …

Background: There is evidence that amyotrophic lateral sclerosis (ALS), also known as motor
neuron disease (MND), is more common in men than in women and that gender influences …

Background and Purpose— Cerebrovascular disease can complicate head and neck
radiotherapy and result in transient ischemic attack and ischemic stroke. Although the incidence of …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a lifetime risk
of one in 350 people and an unmet need for disease-modifying therapies. We conducted a …

Background and Purpose— To assess the prevalence of premorbid undernutrition and its
impact on outcomes 1 month after stroke. Methods— The study recruited from consecutive …

The use of nonlinear devices such as rectifiers or converters, power supplies and other devices
utilizing solid-state switching has increased in industry during. Unfortunately, the effect of …

Objective To determine the prevalence of hypermetabolism, relative to body composition, in
amyotrophic lateral sclerosis (ALS) and its relationship with clinical features of disease and …

Background There is reported to be a decline in immune function and an alteration in the
frequency of circulating lymphocytes with advancing age. There are also differences in ageing …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, leading to
death within an average of 2–3 years. A cure is yet to be found, and a single disease-…